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Dear Editor, 
A 67-year-old man of Kosovar-Albanian ethnic ori-
gin (skin phenotype IV) presented to our dermatol-
ogy clinic with generalized hyperpigmented patches 
and plaques all over the body, so-called melanoeryth-
roderma (Figure 1). The lesions, which first appeared 
nearly six years ago, developed gradually; they were 
diagnosed as mycosis fungoides (MF), and were sub-
sequently treated only with topical corticosteroids. 
We performed further examinations upon admis-
sion to our department. Relevant laboratory param-
eters – blood cell count, LDH, urinalysis, and serum 
chemistry – were within normal limits. Endocrino-
logical examination excluded Addison disease, and 
the patient was not receiving any drugs that could 
cause skin hyperpigmentation. Chest-abdomen-
pelvis computed tomography (CT) scan and sternal 
puncture were normal. Flow cytometric immuno-
phenotyping revealed less than 5% aberrant T-cells. 
Histopathology and immunohistochemistry of skin 
specimens revealed lichenoid infiltration of small- to 
medium-sized atypical T-lymphocytes within the up-
per dermis, epidermotropic lymphocytes with sever-
al Pautrier’s microabscesses (Darier’s nests), pigment 
incontinence, abundant melanophages in the papil-
lary dermis (Figure 2, a, b), and the T-cell CD4+CD7-
CD8+ phenotype (Figure 2, c, d). Based on the clinical 
picture, histopathology, and immunohistochemistry 
the diagnosis of hyperpigmented mycosis fungoides 
(MF) stage IIIA (T4N0M0B0) was established. Skin-ori-
ented therapy (retinoids-PUVA) resulted in slight im-
provement.
Hyperpigmented MF is a rare, uncommon, clini-
cal variant of MF, with a predilection for dark-skinned 
people (1). Only a few cases of hyperpigmented MF 
have been reported so far, and our case being one of 
them (2-5). Hyperpigmented patches or/and plaques 
Figure 1. Clinical presentation of hyperpigmented myco-
sis fungoides – generalized hyperpigmented patches and 
plaques (melanoerythroderma).
Figure 2. (a, b) Lichenoid infiltration of small- to medium-
sized atypical T-lymphocytes within the upper dermis, epi-
dermotropic lymphocytes with several Pautrier’s microab-
scesses (Darier’s nests), pigment incontinence, abundant 
melanophages in the papillary dermis (hematoxylin and 
eosin ×4). (c) Immunohistochemistry; staining for CD4 
highlights the positive T-lymphocyte cells. (d) CD8+ (hema-
toxylin and eosin ×40).
132 ACTA DERMATOVENEROLOGICA CROATICA
dominate the clinical picture. Hyperpigmented MF is 
characterized by a predominantly CD8+ epidermo-
tropic T-cell phenotype, although different pheno-
types have been reported (CD4+ or CD4-CD8-) (2). His-
topathologically, interface changes, pigment inconti-
nence and melanophages are usually found in addi-
tion to the classical findings of early MF (1). The exact 
mechanism of hyperpigmentation is not well under-
stood. Hyperpigmented MF had an indolent course 
in most reported cases, and skin-directed therapy is 
therefore the treatment of choice. Although MF and 
its hyperpigmented variant is a lymphoma of low-
grade malignancy, large-cell transformation (CD30+) 
of hyperpigmented MF can occur (1). 
These rare cases of special clinical MF variants 
are extremely valuable and can help us investigate 
and understand the pathophysiology of the disease. 
Treatment and close follow-up is mandatory in the 
hyperpigmented variant of MF.
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